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Background:	Exposure	of	rats	to	chronic	stress	is	able	to	produce	functional	alterations	that	
are	associated	with	different	psychiatric	disorders,	which	may	be	target	of	pharmacological	
intervention.	 The	 aim	 of	 the	 present	 study	 was	 to	 investigate	 the	 ability	 of	 a	 chronic	
treatment	with	lurasidone	in	normalizing	the	behavioral	and	molecular	changes	produced	by	
chronic	mild	stress	(CMS)	in	rats.	
Methods:	 Adult	 male	 Wistar	 rats	 were	 exposed	 to	 CMS	 for	 2	 weeks	 and	 sucrose	
consumption	was	used	 to	 identify	 rats	 that	were	 susceptible	 to	 the	manipulation.	Control	
and	CMS-susceptible	rats	were	then	randomized	to	receive	chronic	vehicle	or	lurasidone	(3	
mg/kg/day)	 for	 5	more	weeks,	while	 continuing	 the	 stress	 procedure	 (n¼10/experimental	
group).	 Animals	 were	 tested	 for	 anhedonia	 and	 for	 cognitive	 impairment	 before	 being	
sacrificed	for	the	dissection	of	brain	regions	to	be	used	for	the	molecular	analyses.	
Results:	CMS	produced	a	significant	reduction	of	sucrose	 intake	 (-49%,	p<0.001)	as	well	as	
cognitive	 impairment,	 which	 were	 normalized	 by	 chronic	 lurasidone	 treatment.	 Rats	
exposed	 to	 CMS	 also	 display	 a	 significant	 reduction	 of	 parvalbumin	 expression	 in	 dorsal	
hippocampus	 (-58%,	p<0.001),	an	effect	 that	was	associated	with	a	dysregulation	of	 redox	
mechanisms.	 Interestingly	 these	 abnormalities	 were	 counteracted	 by	 chronic	 lurasidone	
administration.	
Conclusions:	 Our	 results	 demonstrate	 that	 exposure	 to	 CMS	 produces	 functional	 and	
molecular	alterations,	which	are	relevant	for	different	‘domains’	of	psychiatric	disorders.	We	
show	that	 lurasidone	treatment	 is	capable	of	normalizing	such	changes	and	may	therefore	
promote	 resilience	 toward	 adverse	 environmental	 conditions,	 such	 as	 stress,	 which	
represents	a	major	vulnerability	element	in	the	etiology	of	mental	illness.	
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